Skip to content
Bacterial STIs: The DoxyPEP Trial episode artwork

Oct 28, 2022 8 min

Bacterial STIs: The DoxyPEP Trial

from BMJ talk medicine Hosted by BMJ Group

Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm. Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, based in Seattle (WA)join Dr Fabiola Martin, STI's Podcast editor, in this short interview. Please listen to a recent podcast on the wider subject of Bacterial STIs: https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/sti Related links: https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds academic.oup.com/cid/article/70/6/1247/5557867 www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/ To hear more episodes of the STI Podcast, please subscribe: https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Bacterial STIs: The DoxyPEP Trial

0:00 8:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of BMJ talk medicine?

This episode is 8 minutes long.

When was this BMJ talk medicine episode published?

This episode was published on October 28, 2022.

Can I download this BMJ talk medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.